IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA) (ALCADIA)
This study has been completed.
Sponsor:
Naofumi Takehara
Collaborators:
National Cerebral and Cardiovascular Center
Translational Research Informatics Center, Kobe, Hyogo, Japan
Asahikawa Medical College
Information provided by (Responsible Party):
Naofumi Takehara, Kyoto Prefectural University of Medicine
ClinicalTrials.gov Identifier:
NCT00981006
First received: September 19, 2009
Last updated: March 31, 2015
Last verified: March 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2013 |
| Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):